Genome & Company (KOSDAQ:314130)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,670.00
+65.00 (2.50%)
At close: Aug 4, 2025, 3:30 PM KST

HashiCorp Revenue

Genome & Company had revenue of 6.35B KRW in the quarter ending March 31, 2025, with 49.11% growth. This brings the company's revenue in the last twelve months to 29.84B, up 86.35% year-over-year. In the year 2024, Genome & Company had annual revenue of 27.74B with 94.07% growth.

Revenue (ttm)
29.84B
Revenue Growth
+86.35%
P/S Ratio
2.72
Revenue / Employee
304.46M
Employees
98
Market Cap
81.29B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202427.74B13.45B94.07%
Dec 31, 202314.30B211.39M1.50%
Dec 31, 202214.08B13.63B3,021.27%
Dec 31, 2021451.25M300.66M199.67%
Dec 31, 2020150.58M104.75M228.54%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition